R

Active Director Director DIN 09537805
DIN 09537805 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Ranbir

Data last updated:

Ranbir is a Director at Molsmed Drugs Private Limited (since 2022). The company operates in Chemicals. Molsmed Drugs Private Limited reported revenue of ₹40.9 Lakh (FY 2025).

DIN 09537805
Primary Designation Director
Industry Chemicals
First Appointment 16 Mar 2022
Oldest Company Age 4 yrs
Largest company Molsmed Drugs Private Limited · ₹40.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Molsmed Drugs Private Limited U24230HR2022PTC102058
Director16 Mar 20222022₹40.9 Lakh (FY 2025)Active

Board colleagues of Ranbir

NameDINCompanyDesignation
Raghbir Singh09468565Molsmed Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Molsmed Drugs Private Limited
Premium access

Shareholding and investment profile for Ranbir

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranbir

Ranbir currently holds 1 directorship: Molsmed Drugs Private Limited (Director, since 16 Mar 2022, revenue ₹40.9 Lakh (FY 2025)).

Ranbir was first appointed on 16 Mar 2022 as Director at Molsmed Drugs Private Limited.

The current boards of Ranbir's companies include Raghbir Singh (Molsmed Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available